Skip to main content

SurpassMD vs Fridays: Flat GLP-1 Pricing vs Coaching Compared

By the Peptide Dossier Editorial TeamUpdated How we source

Peptide Dossier and SurpassMD share ownership. We receive no referral fee or commission. Read our ownership disclosure.

SurpassMD offers compounded semaglutide as low as $114/month and tirzepatide as low as $177/month, flat across every dose, with cold shipping within 48 hours of approval, an oral semaglutide option and nutrition guidance. Fridays also advertises both compounded medicines. Its strengths are 1:1 nutritionist coaching, ongoing support and insurance navigation for brand-name medication. The useful choice is the program and payment structure you will actually use.

Advertised Plans and Services: October 28, 2026

Advertised provider plans and services checked October 28, 2026
FeatureSurpassMDFridays
Compounded semaglutideAs low as $114/mo; flatPromotion from $99/mo; standard footer $150/mo paid annually / $249/mo month-to-month
Semaglutide annual standard offerNo prepayment lump sum requiredStandard footer $150/mo paid annually; promotions differ
Compounded tirzepatideAs low as $177/mo; flatPromotion from $198/mo; standard footer $240/mo paid annually / $359/mo month-to-month
Dose escalationFlat — no increase with doseOffer-specific base plan; do not infer price from dose alone
Brand-name pathNot offeredOzempic and Zepbound advertised; insurance help
Oral semaglutideOral semaglutide; needle-freeBranded Wegovy pill advertised; compounded oral offer not established
Nutrition & coachingNutrition guidance included1:1 nutritionist and ongoing support
Insurance supportCash-pay onlyYes, for brand medications
ShippingCold, within 48 hours of approvalOrder-specific estimate; no delivery deadline verified
BillingHSA/FSA, Klarna, cancel anytimePromotional, monthly and annual standard offers; terms vary
Coverage50 states + DCSubject to state and clinical eligibility

Program vs Medication: What You Are Actually Buying

Checked October 28, 2026: Fridays’ pricing page advertises semaglutide from $99/month and tirzepatide from $198/month in promotional panels. The same page’s standard-plan footer lists semaglutide at $150/month paid annually or $249/month month-to-month, and tirzepatide at $240/month paid annually or $359/month month-to-month. These are distinct advertised offers, not one interchangeable checkout price. SurpassMD’s $114/$177 as-low-as rates reflect its longest subscription option without a prepayment lump sum and stay flat as dose changes. Related reading: GLP-1 tapering.

Fridays’ insurance-navigation service can be valuable when a plan covers an appropriate brand-name prescription. Coverage, deductibles, copays and any platform charge determine the actual patient cost; this review does not assign every insured patient a fixed copay. Read whether your plan covers GLP-1s for coverage questions. To explore the provider side of this decision, our GLP-1 Program Guide compares online weight-management programs.

Verdict: Which Should You Choose?

Choose SurpassMD for the flat $114/$177 as-low-as offers, no dose-based increase, cold shipping within 48 hours, oral semaglutide and included nutrition guidance. Choose Fridays when you will use its 1:1 coaching or brand-name insurance support. Fridays’ $99 semaglutide promotion is a lower headline than SurpassMD’s $114 offer, while SurpassMD keeps its stated rate flat across doses without a prepayment lump sum. The complete commitment and renewal terms decide the better fit.

Full reviews: SurpassMD review and Fridays review. See also best GLP-1 telehealth providers and the full price comparison.

Frequently Asked Questions

SurpassMD advertises semaglutide as low as $114/month, flat across doses, on its longest subscription option without a prepayment lump sum. Checked October 28, Fridays’ pricing page shows a $99/month promotion alongside a standard footer of $150/month paid annually or $249/month month-to-month. Those offers have different commitment and renewal conditions, so neither headline alone establishes the cheapest total plan.

Fridays advertises 1:1 nutritionist coaching, ongoing chat support, regular clinician consultations and insurance-navigation help for brand-name medications. SurpassMD includes nutrition guidance; Fridays’ more structured coaching and insurance service are its distinct strengths in this comparison.

Both advertise compounded tirzepatide. SurpassMD is as low as $177/month, flat across doses. Fridays’ current pricing page shows a promotion from $198/month and a standard footer of $240/month paid annually or $359/month month-to-month; it also advertises brand-name Zepbound. Match the specific offer and payment commitment before comparing totals.

Prepayment trades a lower advertised monthly figure for an upfront commitment and refund restrictions. Fridays’ standard footer lists $150/month paid annually, while current promotional panels show different prices. SurpassMD’s as-low-as $114 rate requires no prepayment lump sum and is cancel-anytime. Review the exact offer and your treatment plan before committing for a year.

SurpassMD advertises cold shipping within 48 hours of provider approval. Fridays provides online intake, clinician review, ongoing coaching and insurance-navigation support. A dispatch promise and a delivery estimate measure different stages; the reviewed Fridays pricing page does not establish a single delivery deadline for every order. Both advertise HSA/FSA payment options.

Choose SurpassMD for flat pricing as low as $114 semaglutide or $177 tirzepatide across all doses, 48-hour cold shipping, an oral semaglutide option and nutrition guidance. Choose Fridays for 1:1 accountability coaching or help pursuing insured brand-name medication. Compare its current promotional offer with its standard-plan commitment rather than assuming the $150 annual figure is always the best available price.

Compounded medications are not FDA-approved or reviewed for safety, effectiveness, or quality. A prescription is never guaranteed; eligibility is determined by an independent licensed provider.